Patents-Review.com
🔗 Permalink
Assignee profile:

PHARMALEADS

City:

Paris

Country:

France

Published Applications:

15

Last publication date:

2021-07-15

Patent Grants:

12

Last grant date:

2021-08-17

Top Inventors for applications by PHARMALEADS

These are the the leading inventors for applications assigned to PHARMALEADS:

Recent patent applications by PHARMALEADS

PHARMALEADS based in Paris, FR has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2021-07-15 ✅ Patent 11,090,317 granted on 2021-08-17
US20210213036A1
Human necessities

Aminophosphinic derivatives for preventing and treating eye inflammation

 #2 | 2021-02-25 ✅ Patent 11,648,231 granted on 2023-05-16
US20210052539A1
Human necessities

Amino acid derivatives containing a disulfanyl group in the form of an NEP and APN inhibitor for the prevention and treatment of trigeminal nerve pain

 #3 | 2019-06-06 ✅ Patent 10,688,113 granted on 2020-06-23
US20190167701A1
Human necessities

Methods of treating eye pain with aminophosphinic derivatives

 #4 | 2018-12-06
US20180344753A1
Human necessities

AMINOPHOSPHINIC DERIVATIVES FOR PREVENTING AND TREATING EYE PAIN

 #5 | 2018-10-25 ✅ Patent 10,399,936 granted on 2019-09-03
US20180305308A1
Chemistry; metallurgy

Industrial process for the preparation of (5S, 10S)-10-benzyl-16-methyl-11, 14, 18-trioxo-15, 17, 19-trioxa-2,7,8-trithia-12-azahenicosan-5-aminium(E)-3-carboxyacrylate salt

 #6 | 2016-07-21
US20160206762A1
Human necessities

Agents for the Molecular Imaging of Serine-Protease in Human Pathologies

 #7 | 2015-10-22 ✅ Patent 9,388,129 granted on 2016-07-12
US20150299116A1
Chemistry; metallurgy

Mixed inhibitors of aminopeptidase N and neprilysin

 #8 | 2014-06-12 ✅ Patent 10,131,681 granted on 2018-11-20
US20140161839A1
Chemistry; metallurgy

Aminophosphinic derivatives that can be used in the treatment of pain

 #9 | 2013-09-19 ✅ Patent 9,272,054 granted on 2016-03-01
US20130243691A1
Human necessities

Agents for the molecular imaging of serine-protease in human pathologies

 #10 | 2013-08-08
US20130203097A1
Physics

SUBSTRATES THE FLUORESCENCE OF WHICH IS SUPPRESSED, PREPARATION THEREOF, AND USE THEREOF FOR IDENTIFYING, DETECTING, AND ASSAYING LEGIONELLA PNEUMOPHILIA

 #11 | 2011-05-26 ✅ Patent 8,703,747 granted on 2014-04-22
US20110124601A1
Chemistry; metallurgy

Aminophosphinic derivatives that can be used in the treatment of pain

 #12 | 2011-03-24 ✅ Patent 8,466,309 granted on 2013-06-18
US20110071218A1
Chemistry; metallurgy

Amino acid derivatives, method for preparing same, and therapeutic use thereof

 #13 | 2009-08-20 ✅ Patent 7,875,436 granted on 2011-01-25
US20090208993A1
Chemistry; metallurgy

Peptide substrates recognizable by a botulinum toxin A, BoNT/A and the use thereof

 #14 | 2009-05-21 ✅ Patent 8,247,608 granted on 2012-08-21
US20090131509A1
Chemistry; metallurgy

Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors

 #15 | 2009-01-08 ✅ Patent 8,247,609 granted on 2012-08-21
US20090012153A1
Chemistry; metallurgy

Aminoacid derivatives containing a disulfanyl group in the form of mixed disulfanyl and aminopeptidase N inhibitors

Also check out PHARMALEADS's (Paris, France) applicant profile with 6 patent applications submitted.

AssigneeID:

33759 ⎘